Cargando…
Identification of key lipid metabolites during metabolic dysregulation in the diabetic retinopathy disease mouse model and efficacy of Keluoxin capsule using an UHPLC-MS-based non-targeted lipidomics approach
Diabetic retinopathy (DR) is an important complication of diabetes, and is currently the main cause of blindness among young adults in the world. Previous studies have shown that Keluoxin (KLX) capsules have a significant effect on DR in C57BL/KsJ/db(−/−) mice (db/db mice), however the unclear mecha...
Autores principales: | Ge, Nan, Kong, Ling, Zhang, Ai-hua, Sun, Ye, Zhao, Man-qian, Zhang, Bo, Xu, Lei, Ke, Xiao, Sun, Hui, Wang, Xi-jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694764/ https://www.ncbi.nlm.nih.gov/pubmed/35423075 http://dx.doi.org/10.1039/d0ra00343c |
Ejemplares similares
-
Chinmedomics Strategy for Elucidating the Pharmacological Effects and Discovering Bioactive Compounds From Keluoxin Against Diabetic Retinopathy
por: Kong, Ling, et al.
Publicado: (2022) -
Grape Lipidomics: An Extensive Profiling thorough UHPLC-MS/MS Method
por: Masuero, Domenico, et al.
Publicado: (2021) -
Efficacy and safety of Keluoxin capsule in combination with Western medicine for diabetic kidney disease: A systematic review and meta-analysis
por: Zhang, Wenhua, et al.
Publicado: (2023) -
Quantitative Lipidomic Analysis of Osteosarcoma Cell-Derived Products by UHPLC-MS/MS
por: Casati, Sara, et al.
Publicado: (2020) -
Identification of Metabolites of Eupatorin in Vivo and in Vitro Based on UHPLC-Q-TOF-MS/MS
por: Li, Luya, et al.
Publicado: (2019)